Related references
Note: Only part of the references are listed.Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case-Control Study in Denmark
Jaclyn Lee Fong Bosco et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Matteo Monami et al.
DIABETES CARE (2011)
Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
J. A. Johnson et al.
DIABETOLOGIA (2011)
Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies
C. J. Wotton et al.
DIABETOLOGIA (2011)
Intensive glucose control and risk of cancer in patients with type 2 diabetes
G. Stefansdottir et al.
DIABETOLOGIA (2011)
Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort
Dorothee M. Baur et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Emily Herrett et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Edoardo Mannucci et al.
DIABETES CARE (2010)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Does diabetes therapy influence the risk of cancer?
U. Smith et al.
DIABETOLOGIA (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens et al.
DIABETOLOGIA (2009)
Insulin glargine and malignancy: an unwarranted alarm
Stuart J. Pocock et al.
LANCET (2009)
Antidiabetic Medication and Prostate Cancer Risk: A population-based Case-Control Study
Teemu J. Murtola et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: A case-control study in Korea
Yong Woo Chung et al.
DISEASES OF THE COLON & RECTUM (2008)
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients - A retrospective cohort study
M. Monami et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2008)
Thiazolidinedione Therapy Is Not Associated With Increased Colonic Neoplasia Risk in Patients With Diabetes Mellitus
James D. Lewis et al.
GASTROENTEROLOGY (2008)
Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-retated mortality
M. Monami et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2007)
Cancer risks in thiazolidinedione users compared to other anti-diabetic agents
Carol Koro et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
Rangaswamy Govindarajan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database
Frank de Vries et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
YX Yang et al.
GASTROENTEROLOGY (2004)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
